The Translational Breast Cancer Research Consortium had two presentations at the 2022 ASCO Meeting. Presentations included:

Exploring Homologous Recombination Deficiency Thresholds for Predicting Response to
Platinum-Based Treatment in Triple Negative Breast Cancer (TBCRC 008 & 030); Abstract: #525

TBCRC 057: An online survey about anxiety and willingness to participate in breast
cancer clinical trials during the COVID-19 pandemic; Abstract: #1564